Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C - PubMed (original) (raw)
Comparative Study
. 1984 Oct 9;23(21):5036-41.
doi: 10.1021/bi00316a032.
- PMID: 6238627
- DOI: 10.1021/bi00316a032
Comparative Study
Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C
H Hidaka et al. Biochemistry. 1984.
Abstract
Naphthalenesulfonamides such as N-(6-amino-hexyl)-5-chloro-1-naphthalenesulfonamide (W-7) are potent calmodulin (CaM) antagonists and act upon several protein kinases at higher concentration. When the naphthalene ring was replaced by isoquinoline, the derivatives were no longer CaM antagonists but retained the ability to inhibit protein kinases, and some of the derivatives exhibited selective inhibition toward a certain protein kinase. cAMP-dependent, cGMP-dependent, and Ca2+-phospholipid-dependent (protein kinase C) protein kinases were inhibited significantly by addition of 10(-6) M N-[2-(methylamino)ethyl]-5-isoquinoline-sulfonamide (H-8) and 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7). H-8 was the most active of the inhibitors in this series and inhibited more markedly cyclic nucleotide dependent protein kinases, than other kinases, while the derivative with the sulfonylpiperazine residue (H-7) was the most potent in inhibiting protein kinase C. Apparent Ki values of H-8 were 0.48 and 1.2 microM for cGMP-dependent and cAMP-dependent protein kinases, respectively, and the Ki value of H-7 for protein kinase C was 6 microM. Both the holoenzyme and the catalytic subunit (or fragment), which is active without an enzyme activator, are susceptible to these compounds with a similar concentration dependency, thereby indicating that the inhibitory effect is attributed to the direct interaction of the compound with the active center of the enzyme but not with the enzyme activator. The inhibitions were freely reversible and of the competitive type with respect to ATP and of the noncompetitive type with respect to the phosphate acceptor.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
Inagaki M, Kawamoto S, Itoh H, Saitoh M, Hagiwara M, Takahashi J, Hidaka H. Inagaki M, et al. Mol Pharmacol. 1986 Jun;29(6):577-81. Mol Pharmacol. 1986. PMID: 2872589 - Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
Hagiwara M, Inagaki M, Watanabe M, Ito M, Onoda K, Tanaka T, Hidaka H. Hagiwara M, et al. Mol Pharmacol. 1987 Jul;32(1):7-12. Mol Pharmacol. 1987. PMID: 2955213 - Selective inhibition of cyclic AMP-dependent protein kinase by isoquinoline derivatives.
Lu ZX, Quazi NH, Deady LW, Polya GM. Lu ZX, et al. Biol Chem Hoppe Seyler. 1996 Jun;377(6):373-84. doi: 10.1515/bchm3.1996.377.6.373. Biol Chem Hoppe Seyler. 1996. PMID: 8839983 - Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H. Chijiwa T, et al. J Biol Chem. 1990 Mar 25;265(9):5267-72. J Biol Chem. 1990. PMID: 2156866 - Regulation of contractile activity in vascular smooth muscle by protein kinases.
Silver PJ. Silver PJ. Rev Clin Basic Pharm. 1985 Jul-Dec;5(3-4):341-95. Rev Clin Basic Pharm. 1985. PMID: 3029813 Review.
Cited by
- Loss of glucose-stimulated β-cell Nr4a1 expression impairs insulin secretion and glucose homeostasis.
Herring JA, Crabtree JE, Hill JT, Tessem JS. Herring JA, et al. Am J Physiol Cell Physiol. 2024 Oct 1;327(4):C1111-C1124. doi: 10.1152/ajpcell.00315.2024. Epub 2024 Sep 2. Am J Physiol Cell Physiol. 2024. PMID: 39219449 - The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms.
Blednov YA, Shawlot W, Homanics GE, Osterndorff-Kahanek EA, Mason S, Mayfield J, Smalley JL, Moss SJ, Messing RO. Blednov YA, et al. Neuropharmacology. 2024 Oct 1;257:110035. doi: 10.1016/j.neuropharm.2024.110035. Epub 2024 Jun 13. Neuropharmacology. 2024. PMID: 38876310 - Nitrogen atom insertion into indenes to access isoquinolines.
Finkelstein P, Reisenbauer JC, Botlik BB, Green O, Florin A, Morandi B. Finkelstein P, et al. Chem Sci. 2023 Feb 23;14(11):2954-2959. doi: 10.1039/d2sc06952k. eCollection 2023 Mar 15. Chem Sci. 2023. PMID: 36937579 Free PMC article. - Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic drugs in mice.
Blednov YA, Da Costa A, Mason S, Mayfield J, Messing RO. Blednov YA, et al. Neuropharmacology. 2023 Jun 15;231:109508. doi: 10.1016/j.neuropharm.2023.109508. Epub 2023 Mar 18. Neuropharmacology. 2023. PMID: 36935006 Free PMC article. - Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA β3 subunits.
Blednov YA, Da Costa A, Mason S, Mayfield J, Moss SJ, Messing RO. Blednov YA, et al. Neuropharmacology. 2022 Dec 1;220:109255. doi: 10.1016/j.neuropharm.2022.109255. Epub 2022 Sep 21. Neuropharmacology. 2022. PMID: 36152689 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous